February 16, 2017
Vectura achieves royalty cap from GSK’s respiratory products
Vectura Group has reached a royalty cap on net sales of £9 million from selling GSK’s respiratory Ellipta products in 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
February 16, 2017
Baxter International adds ENFit to its portfolio
Baxter International, the company focused on nutrition therapy, has expand its nutrition care portfolio to include the new enteral ENFit syringe and accessory line for patients requiring tube feeding.
February 16, 2017
Pharma companies to grow overseas sales regionally at CPhI South East Asia
The slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers, which are now shifting their focus towards regional exports. Mirroring this trend, international investors and companies are increasingly looking at more business access in Indonesia and across the entire ASEAN economy.
February 15, 2017
Surrozen secures $33 million through Series A financing to fund its research of Wnt signaling in regeneration
A newly formed biopharmaceutical company based in San Francisco, USA, has ensured funds for unlocking research of the therapeutic potential of Wnt signaling, a key for stem-cell maintenance and tissue regeneration.
February 15, 2017
Pharma industry shuns Trump push for radical shift at FDA
U.S. President Donald Trump’s vow to roll back government regulations at least 75 percent is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would make it harder to secure insurance coverage for pricey new medicines.
February 15, 2017
Adocia’s revenue for 2016 down 40% year over year, develops Lispro on its own after Lilly’s deal break-up
Adocia plans to license its diabetes treatment products, especially its most advanced program BioChaperone Lispro. The company’s boss said that cash position of €58 million will enable the company to push BioChaperone Lispro into phase 3 clinical trial.
February 15, 2017
Gilead reports results from HIV treatment study at CROI 2017
Gilead Sciences has announced data from two Phase 3 studies evaluating the safety and efficacy of Genvoya for the treatment of HIV-1 infection in treatment-naïve adults.
February 15, 2017
CEO: Georgia Healthcare Group well positioned for the next few years
“The rapid roll-out of our nationwide ambulatory clinic model, and our significant new participation in the Georgian pharmaceuticals market will continue to create further business development and cost efficiency opportunities over the next few years,” said the group’s CEO Nikoloz Gamkrelidze.
February 15, 2017
Navamedic reports slight increase of EBITDA for Q4 2016
Navamedic, Norwegian medtech and pharmaceutical products company, has reported Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) of €0,6 million which represents small increase comparing to same period last year when company’s EBITDA was slightly under zero.
February 15, 2017
Pharmapack Europe 2017 highlights new developments in pharma packaging and drug delivery
Pharmapack Europe – organised by UBM EMEA – closed its 2017 edition, marking 20 years of its presence, as a major European event for pharmaceutical packaging and drug delivery devices. The top trends that emerged from the two-day event included: patient centricity, traceability, innovation, compliance and adherence.